View Single Post
 
Old Apr 08, 2013, 04:35 PM
emgreen's Avatar
emgreen emgreen is offline
Wise Elder
 
Member Since: Aug 2012
Location: Michigan
Posts: 9,645
In addition to being effective in tandem with antidepressants, Abilify is also an atypical anti-psychotic used to treat bipolar, & other disorders. Having been on both, I can tell you Abilify has far fewer side-effects than Seroquel, so you might look at it as being a good thing he didn't raise your dosage. Why are you so intent on having a "label." Here's the low down on Abilify from RxList:

Schizophrenia

ABILIFY is indicated for the treatment of schizophrenia. The efficacy of ABILIFY was established in four 4-6 week trials in adults and one 6-week trial in adolescents (13 to 17 years). Maintenance efficacy was demonstrated in one trial in adults and can be extrapolated to adolescents [see Clinical Studies].

Bipolar I Disorder

Acute Treatment of Manic and Mixed Episodes

ABILIFY is indicated for the acute treatment of manic and mixed episodes associated with bipolar I disorder, both as monotherapy and as an adjunct to lithium or valproate. Efficacy as monotherapy was established in four 3-week monotherapy trials in adults and one 4-week monotherapy trial in pediatric patients (10 to 17 years). Efficacy as adjunctive therapy was established in one 6-week adjunctive trial in adults [see Clinical Studies].

Maintenance Treatment of Bipolar I Disorder

ABILIFY is indicated for the maintenance treatment of bipolar I disorder, both as monotherapy and as an adjunct to either lithium or valproate. Maintenance efficacy was demonstrated in one monotherapy maintenance trial and in one adjunctive maintenance trial in adults [see Clinical Studies].

Adjunctive Treatment of Major Depressive Disorder

ABILIFY is indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD). Efficacy was established in two 6-week trials in adults with MDD who had an inadequate response to antidepressant therapy during the current episode [see Clinical Studies].